BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 24343222)

  • 1. Febrile ulceronecrotic Mucha-Habermann disease.
    Luo DQ
    Cutis; 2013 Nov; 92(5):E9-E12. PubMed ID: 24343222
    [No Abstract]   [Full Text] [Related]  

  • 2. Febrile ulceronecrotic Mucha-Habermann disease: a rare dermatological emergency.
    Helbling I; Chalmers RJ; Yates VM
    Clin Exp Dermatol; 2009 Dec; 34(8):e1006-7. PubMed ID: 20055819
    [No Abstract]   [Full Text] [Related]  

  • 3. Febrile ulceronecrotic Mucha-Habermann disease: a case report and review of the literature.
    Sotiriou E; Patsatsi A; Tsorova C; Lazaridou E; Sotiriadis D
    Acta Derm Venereol; 2008; 88(4):350-5. PubMed ID: 18709304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Febrile ulceronecrotic Mucha-Habermann disease with extensive skin necrosis in intertriginous areas.
    Yang CC; Lee JY; Chen W
    Eur J Dermatol; 2003; 13(5):493-6. PubMed ID: 14693498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Febrile ulceronecrotic Mucha-Habermann disease].
    Arellano Lorca J; Yáñez Silva I; Soto Vilches F; Luna Heine A; Corredoira Salum Y
    Rev Med Chil; 2016 Sep; 144(9):1214-1217. PubMed ID: 28060985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Febrile ulceronecrotic Mucha-Habermann disease: proposed diagnostic criteria and therapeutic evaluation.
    Nofal A; Assaf M; Alakad R; Amer H; Nofal E; Yosef A
    Int J Dermatol; 2016 Jul; 55(7):729-38. PubMed ID: 26695875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Febrile ulceronecrotic Mucha Habermann disease mimicking aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma: a diagnostic challenge.
    Lalevee S; Ortonne N; Hotz C; Schlemmer F; Beldi-Ferchiou A; Delfau-Larue MH; Wolkenstein P; Chosidow O; Ingen-Housz-Oro S
    Eur J Dermatol; 2018 Dec; 28(6):834-835. PubMed ID: 30325315
    [No Abstract]   [Full Text] [Related]  

  • 8. Febrile ulceronecrotic Mucha-Habermann disease in an 8-year-old boy responding to methotrexate.
    Alratrout J; Alshammasi F; Ansari N
    Int J Dermatol; 2016 Nov; 55(11):1205-1209. PubMed ID: 27368714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Febrile ulceronecrotic Mucha-Habermann disease with exuberant mucosal involvement: case report].
    Cumming MM; Salathiel AS; Paino MA; Delort S; Roselino AM
    An Bras Dermatol; 2009; 84(6):655-8. PubMed ID: 20191178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Febrile ulceronecrotic pityriasis lichenoides et varioliformis acuta.
    Fink-Puches R; Soyer HP; Kerl H
    J Am Acad Dermatol; 1994 Feb; 30(2 Pt 1):261-3. PubMed ID: 8288786
    [No Abstract]   [Full Text] [Related]  

  • 11. Intravenous immunoglobulins: a valuable asset in the treatment of a case of septic febrile ulceronecrotic Mucha-Habermann disease.
    Pyrpasopoulou A; Athyros VG; Karagiannis A; Chrysomallis F; Zamboulis C
    Dermatology; 2007; 215(2):164-5. PubMed ID: 17684382
    [No Abstract]   [Full Text] [Related]  

  • 12. A case of ulceronecrotic Mucha-Habermann disease with pulmonary involvement.
    Aydingöz IE; Kocaayan N; Mansur AT; Pekcan S; Arman A
    Dermatology; 2006; 212(4):388-90. PubMed ID: 16707893
    [No Abstract]   [Full Text] [Related]  

  • 13. Febrile ulceronecrotic Mucha-Habermann disease: a case report and review of the literature.
    Suárez J; López B; Villalba R; Perera A
    Dermatology; 1996; 192(3):277-9. PubMed ID: 8726649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Febrile ulceronecrotic Mucha-Habermann disease: a case report and a review of the literature.
    Aytekin S; Balci G; Duzgun OY
    Dermatol Online J; 2005 Dec; 11(3):31. PubMed ID: 16409927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Febrile ulceronecrotic Mucha-Habermann disease].
    Dupin A; Bosset D; Atger L; Chevallier B; Saiag P; Benoist G
    Arch Pediatr; 2016 Jan; 23(1):82-5. PubMed ID: 26552626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Febrile ulceronecrotic Mucha-Habermann disease in a young boy: a case report and review of the literature.
    Yamada K; Motegi S; Matsushima Y
    Acta Derm Venereol; 2014 Sep; 94(5):603-4. PubMed ID: 24473967
    [No Abstract]   [Full Text] [Related]  

  • 17. Transition of pityriasis lichenoides et varioliformis acuta to febrile ulceronecrotic Mucha-Habermann disease is associated with elevated serum tumour necrosis factor-alpha.
    Tsianakas A; Hoeger PH
    Br J Dermatol; 2005 Apr; 152(4):794-9. PubMed ID: 15840118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete resolution of febrile ulceronecrotic Mucha-Habermann disease following infliximab therapy.
    Kreuter A; Knispel S; Wieland U; Oellig F; Tigges C
    J Dtsch Dermatol Ges; 2016 Feb; 14(2):184-6. PubMed ID: 26790133
    [No Abstract]   [Full Text] [Related]  

  • 19. Febrile ulceronecrotic Mucha-Habermann disease: a case with systemic symptoms managed with subcutaneous methotrexate.
    Lin CY; Cook J; Purvis D
    Australas J Dermatol; 2012 Nov; 53(4):e83-6. PubMed ID: 23157793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Febrile ulceronecrotic Mucha-Habermann disease mimicking Kawasaki disease.
    Weins AB; Theiler M; Bogatu B; Kerl K; Pleimes M; Pachlopnik-Schmid J; Weibel L
    J Dtsch Dermatol Ges; 2020 Feb; 18(2):140-142. PubMed ID: 31814284
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.